Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
Lopez Valdes
Eva
E
Posada Rodriguez
Ignacio Javier
IJ
Bilbao-Calabuig
Rafael
R
D001072:Apraxias / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001764:Blepharospasm / Q000150:complications / Q000503:physiopathology*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D019636:Neurodegenerative Diseases / Q000150:complications / Q000503:physiopathology*; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A